What the Midjourney Body Scanner Is—and Why It Matters
The Midjourney body scanner is an ultrasound-based full-body medical imaging machine designed to capture a 3D map of a person’s internal tissues in about 60 seconds inside a spa-like setting, but it is launching without FDA clearance for diagnosis, raising new questions about safety, regulation, and how far non‑traditional tech firms should go when entering health care hardware. Midjourney, known for AI image generation, has set up a new division called Midjourney Medical to drive this move from digital art into AI health imaging hardware. Founder David Holz has promoted the scanner as “the first entirely new whole-body medical imaging technology in five decades,” aiming for MRI-like images using sound instead of radiation or magnets. For now, the company frames the first product as a body composition map, not a diagnostic tool, while it works toward formal FDA medical device approval.
From AI Images to a Full-Body Ultrasound Spa
Midjourney built its reputation by turning text prompts into detailed images, including the famous “cat pictures” that CEO David Holz referenced at the scanner’s launch. Now the company is investing in AI health imaging hardware and planning a full-body ultrasound spa in San Francisco as its first physical site. Users will step onto a platform, slowly descend into a shallow pool, and pass through a ring packed with about half a million ultrasound squares, each sending and receiving sound waves to build a layered 3D body map. The target is a full scan in under 60 seconds, far shorter than the 60 to 90 minutes typical for a full-body MRI, though early prototypes reportedly take closer to 20 minutes. Midjourney admits the spa setting is an unconventional way to debut a medical imaging device, but it sees that setting as key to making scanning feel casual and repeatable.
Borrowed Tech, Hidden Partners, and Transparency Gaps
Behind the futuristic spa experience, the sensor core of the Midjourney body scanner is not fully homegrown. The company licensed ultrasound-on-chip technology from Butterfly Network under a five-year co-development deal worth up to USD 74 million (approx. RM345,200,000), including USD 15 million (approx. RM69,900,000) upfront and USD 10 million (approx. RM46,600,000) per year. That arrangement, disclosed by Butterfly in securities filings, confirms that a critical part of the hardware comes from an established player. At the same time, Midjourney has been vague about other undisclosed partners and components, prompting questions about how much of the stack it truly controls and how open it will be about performance data and failure modes. The company says it is using AI for labeling and segmenting scan results, not for generating the images themselves. For early adopters, the mix of licensed tech, in-house ambition, and partial disclosure makes independent validation even more important.
Launching Before FDA Clearance: What Users Should Know
Midjourney’s scanner is entering a tightly regulated medical imaging market without FDA clearance for diagnostic use, and that has major implications for people tempted by the full-body ultrasound spa pitch. The first product is a non-diagnostic “body composition map” of muscle, fat, bone, and organs, which allows the company to operate outside full medical device rules at the start. Any claim that the system can find or rule out disease would trigger a higher regulatory bar and require FDA medical device approval. Midjourney says it will pursue that in stages through research trials and new hardware generations, with a first spa opening planned in 2027 and more advanced machines in 2028. Until regulators sign off, scans are essentially wellness data. Users should understand that “routine whole-body scans of healthy people tend to surface ambiguous findings that lead to more tests, more cost, and more anxiety,” a risk long noted in imaging research.
Ambition, Risk, and the Road to a Billion Scans
Strategically, the full-body ultrasound spa concept marks a sharp pivot from cloud software to physical AI health imaging hardware, putting Midjourney up against giants like Siemens Healthineers, GE Healthcare, and Philips. The company’s public roadmap is sweeping: the first San Francisco spa in 2027, a third-generation scanner with custom silicon in 2028, and an eventual network of 50,000 scanners delivering a billion scans a month by 2031. Midjourney goes further, claiming “it’s completely possible that with enough early imaging in the future, the world could avoid 30 percent of all deaths and 50 percent of all healthcare costs,” though it admits this is a vision, not a peer-reviewed result. Skeptics point to Midjourney’s lack of experience in shipping medical devices and the unproven performance of the scanner. For users, the promise is early insight into body changes; the tradeoff is stepping into an experiment that regulators and independent researchers have not yet fully tested.
